Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
54.69 USD | -4.09% | -3.94% | -63.97% |
Mar. 04 | HC Wainwright Adjusts Biohaven's Price Target to $63 From $50, Maintains Buy Rating | MT |
Mar. 01 | TD Cowen Ups Price Target on Biohaven to $55 From $35, Keeps Outperform Rating | MT |
- Stock
- Equities
- Stock Biohaven Pharmaceutical Holding Company Ltd. - Nyse
- News Biohaven Pharmaceutical Holding Company Ltd.